CDC. Estimated HIV Incidence in the United States, 2007–2010. HIV Surveillance Supplemental Report. 2012;17 (No. 4). http://www.cdc.gov/hiv/library/reports/surveillance/index.html. Accessed 2 April 2016.
The White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States. 2010. https://www.whitehouse.gov/administration/eop/onap/nhas. Accessed 2 April 2016.
President Barack Obama: Remarks by the President on the National HIV/AIDS Strategy. http://www.whitehouse.gov/the-press-office/remarks-president-national-hivaids-strategy (2013). Accessed 30 Mar 2016.
Holtgrave DR. On the epidemiologic and economic importance of the National AIDS Strategy for the United States. J Acquir Immune Defic Syndr. 2010;55(2):139–42.
Holtgrave DR, Hall HI, Wehrmeyer L, Maulsby C. Costs, consequences and feasibility of strategies for achieving the goals of the National HIV/AIDS strategy in the United States: a closing window for success? AIDS Behav. 2012;16(6):1365–72.
Bonacci RA, Holtgrave DR. Unmet HIV service needs among hispanic men who have sex with men in the United States. AIDS Behav. 2016.
Holtgrave DR, Kim JJ, Adkins C, Maulsby C, Lindsey KD, Johnson KM, et al. Unmet HIV service needs among Black men who have sex with men in the United States. AIDS Behav. 2014;18(1):36–40.
Holtgrave DR. Achieving and advancing the goals of the National HIV/AIDS strategy for the United States. AIDS Behav. 2015;19(2):211–3.
Holtgrave DR. Development of year 2020 goals for the National HIV/AIDS Strategy for the United States. AIDS Behav. 2014;18(4):638–43.
CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas—2013. HIV Surveillance Supplemental Report. 2015; 20 (No. 2). http://www.cdc.gov/hiv/library/reports/surveillance/index.html. Accessed 2 April 2016.
Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. NEJM. 2012;367(5):399–410.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. NEJM. 2011;365(6):493–505.
Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. NEJM. 2010;363(27):2587–99.
Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. NEJM. 2012;367(5):423–34.
The White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States: Updated to 2020. 2015. https://www.aids.gov/federal-resources/national-hiv-aids-strategy/overview/. Accessed 2 April 2016.
CDC. Diagnoses of HIV Infection in the United States and Dependent Areas, 2014. HIV Surveillance Report. 2015; 26. http://www.cdc.gov/hiv/library/reports/surveillance/index.html. Accessed 2 April 2016.
CDC. Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data—United States and 6 Dependent Areas—2012. HIV Surveilance Supplemental Report. 2014;19 (No. 3). http://www.cdc.gov/hiv/library/reports/surveillance/index.html. Accessed 2 April 2016.
Bonacci RA, Holtgrave DR. Simplified estimates of HIV incidence and transmission rates for the USA, 2008–2012. AIDS. 2016;30(2):332–3.
May RM, Anderson RM. The transmission dynamics of human immunodeficiency virus (HIV). Philos Trans R Soc Lond B Biol Sci. 1988;321(1207):565–607.
May RM, Anderson RM. Transmission dynamics of HIV infection. Nature. 1987;326(6109):137–42.
Holtgrave DR. Is the elimination of HIV infection within reach in the United States? Lessons from an epidemiologic transmission model. Public Health Rep. 2010;125(3):372–6.
Siddiqi AE, Hall HI, Hu X, Song R. Population-Based Estimates of Life Expectancy After HIV Diagnosis. United States 2008–2011. J Acquir Immune Defic Syndr. 2016.
Kaiser Family Foundation. U.S. Federal Funding for HIV/AIDS: The President’s FY 2016 Budget Request. (2015). http://kff.org/global-health-policy/fact-sheet/u-s-federal-funding-for-hivaids-the-presidents-fy-2016-budget-request/. Accessed 2 April 2016.
Bradley H, Hall HI, Wolitski RJ, Van Handel MM, Stone AE, LaFlam M, et al. Vital signs: HIV diagnosis, care, and treatment among persons living with HIV—United States, 2011. MMWR. 2014;63(47):1113–7.
Hall HI, Holtgrave DR, Tang T, Rhodes P. HIV transmission in the United States: considerations of viral load, risk behavior, and health disparities. AIDS Behav. 2013;17(5):1632–6.
Skarbinski J, Rosenberg E, Paz-Bailey G, Hall HI, Rose CE, Viall AH, et al. Human immunodeficiency virus transmission at each step of the care continuum in the United States. JAMA Intern Med. 2015;175(4):588–96.
McAllaster C, Fang J. One size does not fit all: what does high impact prevention funding mean for community-based organizations in the deep south? Southern HIV/AIDS Strategy Initiative; 2015.
Song R, Green T. An improved approach to accounting for reporting delay in case surveillance systems. JP J Biostat. 2012;7(1):1–14.